Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort

被引:28
作者
Williams-Gray, CH
Goris, A
Foltynie, T
Brown, J
Maranian, M
Walton, A
Compston, DAS
Sawcer, SJ
Barker, RA
机构
[1] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge CB2 2PY, England
[2] Katholieke Univ Leuven, Lab Clin & Expt Neurol, Louvain, Belgium
基金
英国医学研究理事会;
关键词
D O I
10.1136/jnnp.2005.085019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The LRRK2 G2019S mutation is the commonest genetic cause of Parkinson's disease (PD) identified to date, although estimates of its prevalence in idiopathic disease vary considerably. Our objectives were to determine G2019S mutation frequency in an unselected, community based cohort of idiopathic PD cases from the UK and to describe phenotypic characteristics among carriers. The mutation was present in two of 519 cases (0.4%) and none of 887 control individuals. The true prevalence of the mutation in idiopathic disease, its penetrance, and the phenotypic heterogeneity of associated cases have important implications for genetic screening in the clinical field.
引用
收藏
页码:665 / 667
页数:3
相关论文
共 20 条
  • [1] Clinical features of LRRK2-associated Parkinson's disease in Central Norway
    Aasly, JO
    Toft, M
    Fernandez-Mata, I
    Kachergus, J
    Hulihan, M
    White, LR
    Farrer, M
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (05) : 762 - 765
  • [2] Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease
    Berg, D
    Schweitzer, KJ
    Leitner, P
    Zimprich, A
    Lichtner, P
    Belcredi, P
    Brüssel, T
    Schulte, C
    Maass, S
    Nägele, T
    Wszolek, ZK
    Gasser, T
    [J]. BRAIN, 2005, 128 : 3000 - 3011
  • [3] Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease
    Bialecka, M
    Hui, S
    Klodowska-Duda, G
    Opala, G
    Tan, EK
    Drozdzik, M
    [J]. NEUROSCIENCE LETTERS, 2005, 390 (01) : 1 - 3
  • [4] G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort
    Bras, JM
    Guerreiro, RJ
    Ribeiro, MH
    Januario, C
    Morgadinho, A
    Oliveira, CR
    Cunha, L
    Hardy, J
    Singleton, A
    [J]. MOVEMENT DISORDERS, 2005, 20 (12) : 1653 - 1655
  • [5] Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation
    Deng, H
    Le, WD
    Guo, Y
    Hunter, CB
    Xie, WJ
    Jankovic, J
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (06) : 933 - 934
  • [6] Di Fonzo A, 2005, LANCET, V365, P412
  • [7] LRRK2 mutations in Parkinson disease
    Farrer, M
    Stone, J
    Mata, IF
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Strain, KJ
    Maraganore, DM
    [J]. NEUROLOGY, 2005, 65 (05) : 738 - 740
  • [8] The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
    Foltynie, T
    Brayne, CEG
    Robbins, TW
    Barker, RA
    [J]. BRAIN, 2004, 127 : 550 - 560
  • [9] Common LRRK2 mutation in idiopathic Parkinson's disease
    Gilks, WP
    Abou-Sleiman, PM
    Gandhi, S
    Jain, S
    Singleton, A
    Lees, AJ
    Shaw, K
    Bhatia, KP
    Bonifati, V
    Quinn, NP
    Lynch, J
    Healy, DG
    Holton, JL
    Revesz, T
    Wood, NW
    [J]. LANCET, 2005, 365 (9457) : 415 - 416
  • [10] The dardarin G2019S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases
    Hernandez, D
    Ruiz, CP
    Crawley, A
    Malkani, R
    Werner, J
    Gwinn-Hardy, K
    Dickson, D
    DeVrieze, FW
    Hardy, J
    Singleton, A
    [J]. NEUROSCIENCE LETTERS, 2005, 389 (03) : 137 - 139